Range
2.12 - 2.21
Vol / Avg.
197.4K/556.7K
Div / Yield
-
52 Wk
1.76 - 4.45
Mkt Cap
104.3M
Payout Ratio
-
Open
2.12
P/E
-
EPS
-0.41
Shares
48.3M
Outstanding
48.3M
Total Float
-
Sector: Health Care.Industry: Biotechnology
Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates. Its other product candidates include CD377, CD388, RSV AVC, HIV AVC, and SARS-CoV-2 AVC.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-12
REV
Q1 2021Est.ActualSurprise
EPS-0.310-0.390 -0.0800
REV8.330M2.408M-5.922M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CDTXCidara Therapeutics1.41%104.3M

Cidara Therapeutics Frequently Asked Questions

Q

How do I buy Cidara Therapeutics (CDTX) stock?

A

You can purchase shares of Cidara Therapeutics (NASDAQ: CDTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cidara Therapeutics's (CDTX) competitors?

Q

What is the target price for Cidara Therapeutics (CDTX) stock?

A

The latest price target for Cidara Therapeutics (NASDAQ: CDTX) was reported by Aegis Capital on March 4, 2021. The analyst firm set a price target for 9.00 expecting CDTX to rise to within 12 months (a possible 316.67% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cidara Therapeutics (CDTX)?

A

The stock price for Cidara Therapeutics (NASDAQ: CDTX) is $2.16 last updated Fri Jun 11 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Cidara Therapeutics (CDTX) pay a dividend?

A

There are no upcoming dividends for Cidara Therapeutics.

Q

When is Cidara Therapeutics (NASDAQ:CDTX) reporting earnings?

A
Cidara Therapeutics’s Q2 earnings are confirmed for after-market on August 12, 2021.
Q

Is Cidara Therapeutics (CDTX) going to split?

A

There is no upcoming split for Cidara Therapeutics.

Q

What sector and industry does Cidara Therapeutics (CDTX) operate in?

A

Cidara Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.